Exchange: NASDAQ·Updated 11:55 AM EDT

ODTX Odyssey Therapeutics Inc

$26.31
$0.31
(1.17%)
Today
EarningsNov 5
Mkt Cap$1.28B
Vol45,898.00

About ODTX

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. The company was founded by Gary D. Glick, Melissa Merrick and David L. Pompliano in April 2021 and is headquartered in Boston, MA.
50

Neutral Sentiment

How do you feel about ODTX?

Advertisement|Remove ads.